DDR2 and invasive breast carcinoma: In the present study, we therefore immunolocalized DDR2 and collagen type I in 224 invasive breast carcinoma tissues to clarify the biological and/or clinical significance and subsequently conducted in vitro studies to confirm the role of DDR2 in breast cancer chemoresistance using both chemosensitive and chemoresistant cell lines.